OracleBio Management

Fluoresence Banner

providing high precision, quantitative, digital image analysis services to support pre-clinical and clinical research

Meet the OracleBio Management Team

Our management team has over 75 years of experience of working in R&D within the Pharmaceutical industry.

The management team have considerable knowledge using histology, immunohistochemistry and image analysis techniques and have extensive experience in the development and integration of translational biomarker strategies into drug discovery programs.

Lorcan Sherry, PhD.

Lorcan Sherry, PhD.

Chief Scientific Officer

Lorcan spent 10 years in the pharmaceutical industry as a group leader (Organon, Schering-Plough, Merck & Co.). His group were responsible for performing histology, immunohistochemistry / image analysis and he has considerable experience in developing translational biomarker strategies for projects across various therapeutic areas. He is a Prince 2® qualified project manager and has extensive experience in study management.

John Waller, PhD.

John Waller, PhD.

Chief Operations Officer

John has worked for a total of 15 years as a biology project leader for various pharmaceutical companies including AstraZeneca and Merck & Co. He has expertise in the integration of translational biomarkers into drug discovery programs and has considerable experience in developing in vitro, ex vivo and in vivo models involving image analysis across numerous therapeutic areas. He is a Prince2®-practitioner qualified project manager.

Mark Anderson, BSc.

Mark Anderson, BSc.

Senior Project Manager

Mark worked in the pharmaceutical industry for 30 years (Organon, Schering-Plough, Merck & Co.) using techniques such as in-situ hybridisation, histology and immunohistochemistry, image analysis and the Affymetrix platform. More recently, Mark was a team manager and study director with global responsibility for supporting and developing pre-clinical safety studies at Charles River.

Alison Bigley, FIBMS

Alison Bigley, FIBMS

Clinical Operations Manager

Alison Bigley is a Fellow of the Institute of Biomedical Science and spent 25 years at AstraZeneca as an Associate Principal Scientist and Team Leader in Pathology. She established and led a global digital pathology platform which included programming in proprietary software, application development and GxP validation. Alison has considerable experience in histology, immunohistochemistry and imaging on projects across various therapeutic areas involving pre-clinical, safety and translational medicine.

Matthew Gaffney

Matthew Gaffney

Business Development Manager USA

Matthew Gaffney oversees business development activities in the USA. He is a highly skilled business development manager with previous experience working for a number of contract research organisations in the US and a 19 year portfolio of success within the pharmaceutical and biotechnology industries.

Cliona MacSweeney

Cliona MacSweeney

Business Development Manager Europe

Cliona oversees Business Development activities across Europe. She has spent over 20 years working in the Pharmaceutical industry (Organon, Schering-Plough, Merck & Co, Biotrial). She is a Prince 2 ® practitioner and has extensive experience in non-clinical research.

Find out more about OracleBio at our About Us page